The comorbidity burden of diabetes and stroke: a retrospective study in Beijing, China
Open Access
- 10 February 2025
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-8
Abstract
The high costs associated with diabetes management, coupled with the increasing prevalence of comorbidities, present a significant challenge to China’s healthcare system, with cardiovascular complications being particularly prominent. The purpose of this study was to evaluate the comorbidities of diabetic patients with stroke in Beijing from 2016 to 2018 and the impact on treatment options and associated costs. This retrospective cohort study included diabetic patients enrolled in Beijing’s medical insurance with outpatient medical records. We compared comorbidities, medications, and related treatment costs between stroke and non-stroke patients. A representative sample of 2,853,036 patients with diabetes was identified from the data collected from 2016 to 2018, of which an average of 21.18% of patients reported stroke. A higher percentage of diabetic patients with stroke reported other comorbidities including hypertension, coronary artery disease, dyslipidemia, chronic respiratory disease, and osteoporosis as compared to those without stroke(all p’s < 0.0001). The costs increased dramatically if diabetic patients developed comorbidities, including hypertension, CAD, dyslipidemia, CRD, and osteoporosis. Annual costs of medications were higher for diabetic patients with stroke and any types of comorbidity compared to diabetic patients without stroke (p <.0001, respectively). More types of drugs were used for diabetic patients with stroke and any types of comorbidity. The needs of individuals with diabetes and stroke, including their comorbidity patterns and medical burdens, must be carefully taken into account. Health systems will need to address the increasing demand for diagnosing and managing comorbidities in individuals with diabetes and stroke.Keywords
Funding Information
- the Basic and Applied Basic Research Foundation of Guangdong province (2023A1515012507)
- The National Natural Science Foundation of China (82470846)
- the President Foundation of ZhuJiang Hospital, Southern Medical University (yzjj2023ms07)
This publication has 42 references indexed in Scilit:
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic ReviewValue in Health, 2018
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million peopleThe Lancet Diabetes & Endocrinology, 2015
- Assessing the impact of diabetes-related comorbidities and care on the hospitalization costs for patients with diabetes mellitus in JapanJournal of Diabetes and its Complications, 2012
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Stroke in patients with diabetes mellitusDiabetes/Metabolism Research and Reviews, 2004
- Diabetes and AtherosclerosisJAMA, 2002
- Metabolic modes of action of the statins in the hyperlipoproteinemiasAtherosclerosis, 1998